|
|
| MRD / Regn No. |
: 20170001492 |
Date |
: 15/07/2026 |
| Patient Name |
: Arnab Das |
Age & Gender |
: 45 Yrs. / Male |
| Contact No. |
: 7093883912 |
UHID |
: |
| Ht / Wt / BMI |
: 175 / 84 / 27.43 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
HYPOTHYROIDISM, UNSPECIFIED (02/Dec/2017) | NAFLD (04/Jul/2020) | TYPE 2 DM (01/Jan/2016) | HYPOTHYROIDISM (12/May/2014) | |
|
Subjective |
: |
IS TAKING MEDICATIONS REGULARLY,TOLERATING SEMAGLUTIDE |
|
Objective |
: |
NONE |
|
Analysis |
: |
NAFLD,T2DM,DYSLIPIDEMIA,HYPOTHYROIDISM,OBESITY,CDR > 0.2 |
|
Plan |
: |
HOLD MF AND SGLT2I,SEE ME IN 2 MONTHS WITH TESTING,INCREASE SEMAGLUTIDE 1.7 MG INJECTABLE |
|
| Salient Investigations |
: |
CALCIUM: 9.3 mg/DL | CREATININE: 1.06 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 80.48 mL/min/1.73m2 | TSH : 1.3 mIU/L | UREA: 19 mg/dL | URIC ACID: 3.8 | FASTING PLASMA GLUCOSE (FPG): 94 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.1 % | POST PRANDIAL GLUCOSE (2HPP): 98 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 68 mg/dL | TGL TRIGLYCERIDE: 88 mg/dL | TOTAL CHOLESTEROL: 127 mg/dl | ALBUMIN (SERUM): 4.1 g/dL | ALKALINE PHOSPHOTASE: 97 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 27 U/L | SGPT (ALT): 44 IU/L | TOTAL BILIRUBIN: 0.4 mg/dL | HEMOGLOBIN: 15 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 86.6 fL | PLATELETS: 161 thou cells/ ul | FIB4: 1.14 | WBC WHITE BLOOD CELLS: 860 K/uL | POTASSIUM: 4.4 meQ/L | SODIUM: 137 meq/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
THYROXINE 112 MCG
THYRONORM 112 MCG
Medicine For LOW THYROID |
PO |
1-0-0 |
EMPTY STOMACH
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR B... | |
|
2 |
ROSUVASTATIN 10 MG
CRESTOR 10 MG
Medicine For CHOELSTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY | |
|
3 |
INJECTION SEMAGLUTIDE 1.7 MG
SEMBOLIC 1.7 MG
Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING AND VISION DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 14/Sep/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP HBA1C |
| |
|
| |
|
|
